1991
DOI: 10.1016/0091-3057(91)90404-p
|View full text |Cite
|
Sign up to set email alerts
|

Dopamine D2 receptor blocking effect of imipramine in the rat hippocampus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
7
0

Year Published

1991
1991
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 18 publications
0
7
0
Order By: Relevance
“…Third, there is evidence in other systems that tricyclic antidepressants can antagonize D, family dopamine receptors (Austin et al, 1991;Smialowski, 1991). In spite of this evidence, we cannot rule out the possibility that egl-2(n693) activates an octopaminergic or some other unspecified pathway.…”
Section: Analysis Of the Dominant Egl-2(n693) Mutationmentioning
confidence: 86%
See 2 more Smart Citations
“…Third, there is evidence in other systems that tricyclic antidepressants can antagonize D, family dopamine receptors (Austin et al, 1991;Smialowski, 1991). In spite of this evidence, we cannot rule out the possibility that egl-2(n693) activates an octopaminergic or some other unspecified pathway.…”
Section: Analysis Of the Dominant Egl-2(n693) Mutationmentioning
confidence: 86%
“…6). A clue to the nature of such an inhibitory pathway comes from evidence that tricyclic antidepressants can antagonize D, dopamine receptors (Austin et al, 1991;Smialowski et al, 1991). Since dopamine antagonists can rescue egl-2(n693), we hypothesized that egl-2(n693) activates a negative regulatory dopaminergic pathway that can be blocked by tricyclics and D, dopamine antagonists.…”
Section: Analysis Of the Dominant Egl-2(n693) Mutationmentioning
confidence: 99%
See 1 more Smart Citation
“…Amitriptyline is mainly classified as a neuroleptic and seems to be false-negative in this system. Imipramine has a somewhat higher neuroleptic than antidepressant score, which might be explained by its suggested effect of block ing the dopamine Dy receptor [34], Moreover, both imip ramine and amitriptyline diminish apomorphine-induced hypermotility [35] showing antidopaminergic activity. This may explain the deviating results with imipramine 132 Krijzcr/Koopraan/Olivier Psychotropic Drugs Classified by Pharmaco-ECoG and amitriptyline.…”
Section: Discussionmentioning
confidence: 99%
“…Moreover, chronic treatment with the antidepressant imipramine increases PSA-NCAM expression in the PCX layer II of adult rats ( Sairanen et al, 2007 ). These results are also interesting because imipramine, besides its action as a 5HT and norepinephrine reuptake inhibitor, also blocks D2 receptors ( Smiałowski, 1991 ). This is consistent with the effects that we observe with haloperidol in the present study.…”
Section: Discussionmentioning
confidence: 99%